By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – SQI Diagnostics reported after the close of the market Wednesday that its fourth-quarter 2011 net loss climbed 50 percent on higher professional and consulting fees tied to an acquisition that was not completed and financings.

The Toronto-based microarray diagnostics firm reported revenues of C$5,000 (US$4,884) for the quarter ended Sept. 30, compared to C$14,000 for the fourth quarter of 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.